HumanBioMonitoring-Schoeters - BioDetection Systems

More documents

Recommendations

Info

FLEHS: newborns cord blood (2002-2003)regional variationsAntwerp Ghent Fruitregionpg CALUX-TEQ/g fat 25 17 19 30!Rural Ports NonferroindustCanal,industryincineratorPCB (ng/g fat) 81 43 38 84! 111ppDDEng/g fat)71 76 175! 140! 181HCBng/g fat24 11 13 29! 16 33cadmiumlood 13 13 22
Dose- response relationshipsPilot study• Adolescent girls: retarded breast developmentOR for doubling exposure: 2,1 (1,05-3,8) p=0,02First cycle of HB program 2002-2006• Mothers needed more medical assistance to get pregnantOR for doubling exposure :1,4 (1,09- 1,8) p=0,008• Mothers had reduced risk for miscarriageOR for doubling exposure : 0,81 (0,65-0,99) p=0,04Adjusted for age and smoking,
Page 2 and 3: Outline• An introduction to human
Page 4 and 5: The causal chain:from exposure to e
Page 6 and 7: A brief introduction to HBMspecific
Page 8 and 9: A brief introduction to HBM• Envi
Page 10 and 11: Evaluating time trendsMean lipid-ad
Page 12 and 13: Relation with health effects
Page 14 and 15: o evaluate the efficacity of policy
Page 16 and 17: European initiatives humanbiomonito
Page 18 and 19: The future: The EU Pilot ProjectESB
Page 20 and 21: 2 Main types of HBM activities- SUR
Page 22 and 23: wo protocolsASilicacolumnHexane/DEE
Page 24 and 25: Breast milk monitoringblicationCoun
Page 26 and 27: HBM in FlandersFlanders(1998)EU(199
Page 28 and 29: Effect of gender:Marker PCBs (ng/ g
Page 30 and 31: Determinants of CALUX TEQin adolesc
Page 32 and 33: Correlation between CaluxTEQ and to
Page 34 and 35: Study areas:8 study areas in Flande
Page 38 and 39: HBM in Flanders• Some results-Ris
Page 40 and 41: PitfallsComparison between differen

HumanBioMonitoring-Schoeters - BioDetection Systems

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?